303 related articles for article (PubMed ID: 19157528)
21. Molecular analysis of HPV 16 E6I/E6II spliced mRNAs and correlation with the viral physical state and the grade of the cervical lesion.
Cricca M; Venturoli S; Leo E; Costa S; Musiani M; Zerbini M
J Med Virol; 2009 Jul; 81(7):1276-82. PubMed ID: 19475620
[TBL] [Abstract][Full Text] [Related]
22. Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions.
Wentzensen N; Ridder R; Klaes R; Vinokurova S; Schaefer U; Doeberitz Mv
Oncogene; 2002 Jan; 21(3):419-26. PubMed ID: 11821954
[TBL] [Abstract][Full Text] [Related]
23. MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors.
Peter M; Rosty C; Couturier J; Radvanyi F; Teshima H; Sastre-Garau X
Oncogene; 2006 Sep; 25(44):5985-93. PubMed ID: 16682952
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of single and multiple human papillomavirus types in cervical cancer and precursor lesions in Hubei, China.
Cai HB; Ding XH; Chen CC
Oncology; 2009; 76(3):157-61. PubMed ID: 19174613
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus 16 integration and risk factors associated in anal samples of HIV-1 infected men.
Cañadas MP; Darwich L; Sirera G; Bofill M; Piñol M; Garcia-Cuyas F; Llatjos M; Corbasi P; Clotet B; Videla S;
Sex Transm Dis; 2010 May; 37(5):311-5. PubMed ID: 20065890
[TBL] [Abstract][Full Text] [Related]
26. Diagnosing cervical cancer and high-grade precursors by HPV16 transcription patterns.
Schmitt M; Dalstein V; Waterboer T; Clavel C; Gissmann L; Pawlita M
Cancer Res; 2010 Jan; 70(1):249-56. PubMed ID: 20028865
[TBL] [Abstract][Full Text] [Related]
27. The prognostic significance of HPV-16 genome status of the lymph nodes, the integration status and p53 genotype in HPV-16 positive cervical cancer: a long term follow up.
Hernádi Z; Szarka K; Sápy T; Krasznai Z; Veress G; Póka R
BJOG; 2003 Feb; 110(2):205-9. PubMed ID: 12618167
[TBL] [Abstract][Full Text] [Related]
28. Molecular analysis of cellular loci disrupted by papillomavirus 16 integration in cervical cancer: frequent viral integration in topologically destabilized and transcriptionally active chromosomal regions.
Choo KB; Chen CM; Han CP; Cheng WT; Au LC
J Med Virol; 1996 May; 49(1):15-22. PubMed ID: 8732866
[TBL] [Abstract][Full Text] [Related]
29. Preferential sites for the integration and disruption of human papillomavirus 16 in cervical lesions.
Li H; Yang Y; Zhang R; Cai Y; Yang X; Wang Z; Li Y; Cheng X; Ye X; Xiang Y; Zhu B
J Clin Virol; 2013 Apr; 56(4):342-7. PubMed ID: 23290390
[TBL] [Abstract][Full Text] [Related]
30. Virological characteristics of cervical cancers carrying pure episomal form of HPV16 genome.
Cheung JL; Cheung TH; Yu MY; Chan PK
Gynecol Oncol; 2013 Nov; 131(2):374-9. PubMed ID: 24012799
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites.
Thorland EC; Myers SL; Persing DH; Sarkar G; McGovern RM; Gostout BS; Smith DI
Cancer Res; 2000 Nov; 60(21):5916-21. PubMed ID: 11085503
[TBL] [Abstract][Full Text] [Related]
32. The performance of the HPV16 real-time PCR integration assay.
Ruutu MP; Kulmala SM; Peitsaro P; Syrjänen SM
Clin Biochem; 2008 Apr; 41(6):423-8. PubMed ID: 18206116
[TBL] [Abstract][Full Text] [Related]
33. Disruption of the E2 gene is a common and early event in the natural history of cervical human papillomavirus infection: a longitudinal cohort study.
Collins SI; Constandinou-Williams C; Wen K; Young LS; Roberts S; Murray PG; Woodman CB
Cancer Res; 2009 May; 69(9):3828-32. PubMed ID: 19401452
[TBL] [Abstract][Full Text] [Related]
34. Genomic organization of amplified MYC genes suggests distinct mechanisms of amplification in tumorigenesis.
Herrick J; Conti C; Teissier S; Thierry F; Couturier J; Sastre-Garau X; Favre M; Orth G; Bensimon A
Cancer Res; 2005 Feb; 65(4):1174-9. PubMed ID: 15735000
[TBL] [Abstract][Full Text] [Related]
35. Physical status of HPV-16 in esophageal squamous cell carcinoma.
Si HX; Tsao SW; Poon CS; Wong YC; Cheung AL
J Clin Virol; 2005 Jan; 32(1):19-23. PubMed ID: 15572001
[TBL] [Abstract][Full Text] [Related]
36. HPV type 18 is more oncopotent than HPV16 in uterine cervical carcinogenesis although HPV16 is the prevalent type in Chennai, India.
Berlin Grace VM
Indian J Cancer; 2009; 46(3):203-7. PubMed ID: 19574671
[TBL] [Abstract][Full Text] [Related]
37. Physical status of HPV types 16 and 18 in topographically different areas of genital tumours and in paired tumour-free mucosa.
Badaracco G; Venuti A
Int J Oncol; 2005 Jul; 27(1):161-7. PubMed ID: 15942656
[TBL] [Abstract][Full Text] [Related]
38. [Status of the human DNA papillomavirus in cervical tumors].
Kiselev FL; Kiseleva NP; Kobzeva VK; Gritsko TM; Semenova LA; Pavlova LS; Klaes R; von Knebel Doeberitz M
Mol Biol (Mosk); 2001; 35(3):470-6. PubMed ID: 11443929
[TBL] [Abstract][Full Text] [Related]
39. High HPV 16 viral load is associated with increased cervical dysplasia in Honduran women.
Tábora N; Ferrera A; Bakkers JM; Massuger LF; Melchers WJ
Am J Trop Med Hyg; 2008 May; 78(5):843-6. PubMed ID: 18458323
[TBL] [Abstract][Full Text] [Related]
40. Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells.
Luft F; Klaes R; Nees M; Dürst M; Heilmann V; Melsheimer P; von Knebel Doeberitz M
Int J Cancer; 2001 Apr; 92(1):9-17. PubMed ID: 11279600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
